Literature DB >> 14675192

Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases.

Deborah C Holt1, Katja Fischer, George E Allen, Danny Wilson, Peter Wilson, Robert Slade, Bart J Currie, Shelley F Walton, David J Kemp.   

Abstract

Parasitic infestation of the skin by the mite Sarcoptes scabiei is a significant problem worldwide, particularly in socially disadvantaged communities. A multigene family of at least 24 homologs of a serine protease allergen have been identified in S. scabiei. Surprisingly, the products of all but one of these genes are predicted to be catalytically inactive, due to mutations at a critical triad of amino acids at the active site. We discuss the possibility that these genes for inactivated proteases have been conserved because they mediate a novel host defense evasion strategy that the mite has evolved as an adaptation to parasitism of the epidermis. The identification of this family, and elucidation of its value to the parasite, may present an unanticipated approach to protective vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675192     DOI: 10.1046/j.1523-1747.2003.12621.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  28 in total

1.  Treatment and control of Trixacarus caviae infestation in a conventional guinea pig (Cavia porcellus) breeding colony.

Authors:  Anjan Jyoti Nath
Journal:  J Parasit Dis       Date:  2015-02-14

2.  Monoclonal antibodies against recombinant Der f 3 reveal localization of Der f 3 in the gut and faecal pellets of Dermatophagoides farinae.

Authors:  Zheng-ke Zhan; Kun-mei Ji; Xiao-yu Liu; Zhi-gang Liu; Meng Li; Jia-jie Chen; Jia-na Li; Shi Qiu
Journal:  Exp Appl Acarol       Date:  2010-03-14       Impact factor: 2.132

3.  Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies.

Authors:  Shelley F Walton; Susan Pizzutto; Amy Slender; Linda Viberg; Deborah Holt; Belinda J Hales; David J Kemp; Bart J Currie; Jennifer M Rolland; Robyn O'Hehir
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

4.  Characterization of Sarcoptes scabiei Tropomyosin and Paramyosin: Immunoreactive Allergens in Scabies.

Authors:  Shumaila Naz; Marion Desclozeaux; Kate E Mounsey; Farhana Riaz Chaudhry; Shelley F Walton
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  Ectoparasitic infestations.

Authors:  Jörg Heukelbach; Shelley F Walton; Hermann Feldmeier
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

6.  Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabiei.

Authors:  Simone A Beckham; Sarah E Boyd; Simone Reynolds; Charlene Willis; Masego Johnstone; Angela Mika; Pavla Simerská; Lakshmi C Wijeyewickrema; A Ian Smith; David J Kemp; Robert N Pike; Katja Fischer
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

Review 7.  Problems in diagnosing scabies, a global disease in human and animal populations.

Authors:  Shelley F Walton; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

8.  Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei.

Authors:  Kate E Mounsey; Joseph A Dent; Deborah C Holt; James McCarthy; Bart J Currie; Shelley F Walton
Journal:  Invert Neurosci       Date:  2007-06-30

9.  Characterization and evaluation of a Sarcoptes scabiei allergen as a candidate vaccine.

Authors:  Runhui Zhang; Quwu Jise; Wanpeng Zheng; Yongjun Ren; Xiang Nong; Xuhang Wu; Xiaobin Gu; Shuxian Wang; Xuerong Peng; Songjia Lai; Guangyou Yang
Journal:  Parasit Vectors       Date:  2012-08-16       Impact factor: 3.876

10.  Novel scabies mite serpins inhibit the three pathways of the human complement system.

Authors:  Angela Mika; Simone L Reynolds; Frida C Mohlin; Charlene Willis; Pearl M Swe; Darren A Pickering; Vanja Halilovic; Lakshmi C Wijeyewickrema; Robert N Pike; Anna M Blom; David J Kemp; Katja Fischer
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.